- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 5 residues within 4Å:- Chain A: N.159, T.161
- Chain E: S.213, P.215, W.216
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain E- Hydrophobic interactions: A:T.161
- Hydrogen bonds: E:W.216
NAG-NAG-BMA-MAN-MAN.24: 5 residues within 4Å:- Chain E: N.159, T.161
- Chain I: S.213, P.215, W.216
2 PLIP interactions:1 interactions with chain I, 1 interactions with chain E- Hydrogen bonds: I:W.216
- Hydrophobic interactions: E:T.161
NAG-NAG-BMA-MAN-MAN.46: 5 residues within 4Å:- Chain A: S.213, P.215, W.216
- Chain I: N.159, T.161
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain I- Hydrogen bonds: A:W.216
- Hydrophobic interactions: I:T.161
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 3 residues within 4Å:- Chain A: I.56, N.57, F.88
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.56
- Hydrogen bonds: A:N.57
NAG.11: 4 residues within 4Å:- Chain B: A.147, G.150, S.151, N.154
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.154, B:N.154
NAG.26: 3 residues within 4Å:- Chain E: I.56, N.57, F.88
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:I.56
- Hydrogen bonds: E:N.57
NAG.33: 4 residues within 4Å:- Chain F: A.147, G.150, S.151, N.154
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:N.154, F:N.154
NAG.48: 3 residues within 4Å:- Chain I: I.56, N.57, F.88
2 PLIP interactions:2 interactions with chain I- Hydrophobic interactions: I:I.56
- Hydrogen bonds: I:N.57
NAG.55: 4 residues within 4Å:- Chain J: A.147, G.150, S.151, N.154
2 PLIP interactions:2 interactions with chain J- Hydrogen bonds: J:N.154, J:N.154
- 42 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 4 residues within 4Å:- Chain A: R.84, K.86, D.265, P.267
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: K.44, I.268, G.269, T.270
Ligand excluded by PLIPSO4.7: 1 residues within 4Å:- Chain A: R.51
Ligand excluded by PLIPSO4.8: 4 residues within 4Å:- Chain A: N.75, F.114, N.116, R.144
Ligand excluded by PLIPSO4.9: 3 residues within 4Å:- Chain A: I.28, R.315
- Chain B: A.7
Ligand excluded by PLIPSO4.12: 5 residues within 4Å:- Chain B: R.127, H.159, D.160
- Chain F: M.133, K.139
Ligand excluded by PLIPSO4.13: 5 residues within 4Å:- Chain B: G.13, W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain B: R.25, Q.34
Ligand excluded by PLIPSO4.15: 8 residues within 4Å:- Chain C: T.33, N.35, Y.50, S.51
- Chain D: Y.115, Y.116, G.117
- Ligands: PEG.18
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain C: S.25, R.26
Ligand excluded by PLIPSO4.19: 3 residues within 4Å:- Chain D: F.54, T.56, C.109
Ligand excluded by PLIPSO4.20: 7 residues within 4Å:- Chain D: Y.31, E.102, Y.105, C.106, D.113, Y.114, Y.116
Ligand excluded by PLIPSO4.21: 2 residues within 4Å:- Chain D: A.110, A.111
Ligand excluded by PLIPSO4.22: 2 residues within 4Å:- Chain D: S.7, G.8
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain E: R.84, K.86, D.265, P.267
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain E: K.44, I.268, G.269, T.270
Ligand excluded by PLIPSO4.29: 1 residues within 4Å:- Chain E: R.51
Ligand excluded by PLIPSO4.30: 4 residues within 4Å:- Chain E: N.75, F.114, N.116, R.144
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain E: I.28, R.315
- Chain F: A.7
Ligand excluded by PLIPSO4.34: 5 residues within 4Å:- Chain F: R.127, H.159, D.160
- Chain J: M.133, K.139
Ligand excluded by PLIPSO4.35: 5 residues within 4Å:- Chain F: G.13, W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.36: 2 residues within 4Å:- Chain F: R.25, Q.34
Ligand excluded by PLIPSO4.37: 8 residues within 4Å:- Chain G: T.33, N.35, Y.50, S.51
- Chain H: Y.115, Y.116, G.117
- Ligands: PEG.40
Ligand excluded by PLIPSO4.38: 2 residues within 4Å:- Chain G: S.25, R.26
Ligand excluded by PLIPSO4.41: 3 residues within 4Å:- Chain H: F.54, T.56, C.109
Ligand excluded by PLIPSO4.42: 7 residues within 4Å:- Chain H: Y.31, E.102, Y.105, C.106, D.113, Y.114, Y.116
Ligand excluded by PLIPSO4.43: 2 residues within 4Å:- Chain H: A.110, A.111
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain H: S.7, G.8
Ligand excluded by PLIPSO4.49: 4 residues within 4Å:- Chain I: R.84, K.86, D.265, P.267
Ligand excluded by PLIPSO4.50: 4 residues within 4Å:- Chain I: K.44, I.268, G.269, T.270
Ligand excluded by PLIPSO4.51: 1 residues within 4Å:- Chain I: R.51
Ligand excluded by PLIPSO4.52: 4 residues within 4Å:- Chain I: N.75, F.114, N.116, R.144
Ligand excluded by PLIPSO4.53: 3 residues within 4Å:- Chain I: I.28, R.315
- Chain J: A.7
Ligand excluded by PLIPSO4.56: 5 residues within 4Å:- Chain B: M.133, K.139
- Chain J: R.127, H.159, D.160
Ligand excluded by PLIPSO4.57: 5 residues within 4Å:- Chain J: G.13, W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.58: 2 residues within 4Å:- Chain J: R.25, Q.34
Ligand excluded by PLIPSO4.59: 8 residues within 4Å:- Chain K: T.33, N.35, Y.50, S.51
- Chain L: Y.115, Y.116, G.117
- Ligands: PEG.62
Ligand excluded by PLIPSO4.60: 2 residues within 4Å:- Chain K: S.25, R.26
Ligand excluded by PLIPSO4.63: 3 residues within 4Å:- Chain L: F.54, T.56, C.109
Ligand excluded by PLIPSO4.64: 7 residues within 4Å:- Chain L: Y.31, E.102, Y.105, C.106, D.113, Y.114, Y.116
Ligand excluded by PLIPSO4.65: 2 residues within 4Å:- Chain L: A.110, A.111
Ligand excluded by PLIPSO4.66: 2 residues within 4Å:- Chain L: S.7, G.8
Ligand excluded by PLIP- 9 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.10: 4 residues within 4Å:- Chain A: K.301
- Chain B: R.54
- Chain F: Y.94, E.97
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:K.301, A:K.301, B:R.54
PEG.17: 7 residues within 4Å:- Chain C: P.8, D.86, G.103, G.104
- Chain D: Q.38, G.41, Q.42
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain D- Hydrogen bonds: C:P.8
- Water bridges: D:G.41
PEG.18: 9 residues within 4Å:- Chain C: T.33, N.35, Y.37, A.90, W.92, V.99
- Chain D: Y.115, Y.116
- Ligands: SO4.15
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:Y.37, C:W.92
PEG.32: 4 residues within 4Å:- Chain E: K.301
- Chain F: R.54
- Chain J: Y.94, E.97
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain F- Hydrogen bonds: E:K.301, E:K.301, F:R.54
PEG.39: 7 residues within 4Å:- Chain G: P.8, D.86, G.103, G.104
- Chain H: Q.38, G.41, Q.42
2 PLIP interactions:1 interactions with chain H, 1 interactions with chain G- Water bridges: H:G.41
- Hydrogen bonds: G:P.8
PEG.40: 9 residues within 4Å:- Chain G: T.33, N.35, Y.37, A.90, W.92, V.99
- Chain H: Y.115, Y.116
- Ligands: SO4.37
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:Y.37, G:W.92
PEG.54: 4 residues within 4Å:- Chain B: Y.94, E.97
- Chain I: K.301
- Chain J: R.54
3 PLIP interactions:1 interactions with chain J, 2 interactions with chain I- Hydrogen bonds: J:R.54, I:K.301, I:K.301
PEG.61: 7 residues within 4Å:- Chain K: P.8, D.86, G.103, G.104
- Chain L: Q.38, G.41, Q.42
2 PLIP interactions:1 interactions with chain L, 1 interactions with chain K- Water bridges: L:G.41
- Hydrogen bonds: K:P.8
PEG.62: 9 residues within 4Å:- Chain K: T.33, N.35, Y.37, A.90, W.92, V.99
- Chain L: Y.115, Y.116
- Ligands: SO4.59
2 PLIP interactions:2 interactions with chain K- Hydrogen bonds: K:Y.37, K:W.92
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lee, P.S. et al., Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat Commun (2014)
- Release Date
- 2014-04-16
- Peptides
- Hemagglutinin HA1 chain: AEI
Hemagglutinin HA2 chain: BFJ
Fab F045-092 light chain: CGK
Fab F045-092 heavy chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AB
BF
BJ
BC
LG
LK
LD
HH
HL
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 42 x SO4: SULFATE ION(Non-functional Binders)
- 9 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lee, P.S. et al., Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat Commun (2014)
- Release Date
- 2014-04-16
- Peptides
- Hemagglutinin HA1 chain: AEI
Hemagglutinin HA2 chain: BFJ
Fab F045-092 light chain: CGK
Fab F045-092 heavy chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AB
BF
BJ
BC
LG
LK
LD
HH
HL
H